Live Breaking News & Updates on Subcutaneous Talquetamab Plus Daratumumab

Stay updated with breaking news from Subcutaneous talquetamab plus daratumumab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the MonumenTAL-1 Phase 1 first-in-human. ....

United States , Namita Krishnan , Obrian Kenney , Sen Zhuang , Jessica Moore , Janssen Biotech Inc , American Society Of Hematology Annual Meeting , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , American Society Of Hematology , Receptor Familyc Group , Clinical Research , Department Of Hematology , American Cancer Society , None Of The Janssen Pharmaceutical Companies , Other Administration Reactions , European Commission , Division Of Multiple Myeloma , Exchange Commission , Companies Of Johnson , Amgen Inc , City Of Hope Comprehensive Cancer Center , American Society , Multiple Myeloma , Hematopoietic Cell Transplantation ,

Janssen Presents Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma

/PRNewswire/ The Janssen Pharmaceutical Companies of Johnson & Johnson announced today updated results from the MonumenTAL-1 Phase 1 first-in-human. ....

United States , Namita Krishnan , Obrian Kenney , Sen Zhuang , Jessica Moore , Janssen Biotech Inc , American Society Of Hematology Annual Meeting , Janssen Research Development , Janssen Pharmaceutical Companies , Janssen Pharmaceutical Companies Of Johnson , American Society Of Hematology , Receptor Familyc Group , Clinical Research , Department Of Hematology , American Cancer Society , None Of The Janssen Pharmaceutical Companies , Other Administration Reactions , European Commission , Division Of Multiple Myeloma , Exchange Commission , Companies Of Johnson , Amgen Inc , City Of Hope Comprehensive Cancer Center , American Society , Multiple Myeloma , Hematopoietic Cell Transplantation ,